Artificial Intelligence in Drug Discovery Market to Grow at 30.7% CAGR by 2031 | Atomwise, Schrodinger, Aitia

Los Angeles, United States - QY Research has unveiled its latest study titled "Global Artificial Intelligence in Drug Discovery Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031." This newly released report delivers a comprehensive overview of the global Artificial Intelligence in Drug Discovery market, analyzing the forces shaping its growth trajectory and providing valuable insights for stakeholders, investors, and industry professionals. the research covers key areas including market dynamics, segmentation, regional performance, competitive landscape, and emerging technology trends that are redefining industry standards. Backed by reliable data and expert analysis, the report serves as a trusted guide to understanding both microeconomic and macroeconomic factors driving market evolution.

The global market for Artificial Intelligence in Drug Discovery was estimated to be worth US$ 2281 million in 2024 and is forecast to a readjusted size of US$ 14511 million by 2031 with a CAGR of 30.7% during the forecast period 2025-2031.

Download Free Sample PDF Report (with full TOC, tables, and charts) To Explore Detailed Insights and Forecasts @ https://qyresearch.in/request-sample/service-software-global-artificial-intelligence-in-drug-discovery-market-share-and-ranking-overall-sales-and-demand-forecast-2025-2031

Artificial intelligence in medicine is the use of machine learning models to search medical data and uncover insights to help improve health outcomes and patient experiences. Thanks to recent advances in computer science and informatics, artificial intelligence (AI) is quickly becoming an integral part of modern healthcare. AI algorithms and other applications powered by AI are being used to support medical professionals in clinical settings and in ongoing research. Currently, the most common roles for AI in medical settings are clinical decision support and imaging analysis. Clinical decision support tools help providers make decisions about treatments, medications, mental health and other patient needs by providing them with quick access to information or research that's relevant to their patient. Drug discovery is often one of the longest and most costly parts of drug development. AI could help reduce the costs of developing new medicines in primarily two ways: creating better drug designs and finding promising new drug combinations. With AI, many of the big data challenges facing the life sciences industry could be overcome.

The market for artificial intelligence (AI) in drug discovery is driven by the urgent need to accelerate and reduce the cost of developing new therapeutics, as traditional drug discovery is often slow, expensive, and prone to high failure rates. AI enables rapid identification of drug candidates, predictive modeling of drug-target interactions, and optimization of clinical trial design, significantly shortening development timelines. The explosion of biomedical data, including genomics, proteomics, and real-world clinical datasets, provides a rich foundation for AI algorithms to uncover novel insights. Additionally, rising investment from pharmaceutical companies, biotech firms, and venture capital in AI-driven platforms-combined with advances in deep learning, natural language processing, and generative models-is propelling adoption. Regulatory agencies' increasing openness to AI-assisted drug development workflows also supports the growth of this transformative sector.

Competitive Landscape: -

IBM
Exscientia
Google(Alphabet)
Microsoft
Atomwise
Schrodinger
Aitia
Insilico Medicine
NVIDIA
XtalPi
BPGbio
Owkin
CytoReason
Deep Genomics
Cloud Pharmaceuticals
BenevolentAI
Cyclica
Verge Genomics
Valo Health
Envisagenics
Euretos
BioAge Labs
Iktos
BioSymetrics
Evaxion Biotech
Aria Pharmaceuticals, Inc

The competitive landscape is a must-have information for the market players to withstand the competition present in the global Artificial Intelligence in Drug Discovery market. This further helps the market participants to develop effective strategies to optimize their market positions. Moreover, the competitive analysis helps them to determine potential advantages as well as barriers within the global Artificial Intelligence in Drug Discovery market. This way, they can monitor how their competitors are implementing various strategies including pricing, marketing, and distribution.

Market Drivers and Restraints -

This section of the Artificial Intelligence in Drug Discovery report discusses various drivers and restrains that have shaped the global market. The detailed study of numerous drivers of the market enable readers to get a clear perspective of the market, which includes market environment, government policies, product innovations, breakthroughs, and market risks.

The research report also points out the myriad opportunities, challenges, and market barriers present in the global Artificial Intelligence in Drug Discovery market. The comprehensive nature of the information will help the reader determine and plan strategies to benefit from. Restrains, challenges, and market barriers also help the reader to understand how the company can prevent itself from facing downfall.

Regional Insights -

The report takes readers on a journey through four key regions: United States, Asia-Pacific, and EMEA. Key nations like the United States, Germany, the United Kingdom, China, Japan, South Korea, and more are thoroughly examined. The data is presented in a timeline from 2024 as the base year, with projections extending to 2031.

North America: United States, Canada, Mexico

Latin America: Brazil and other key markets

Asia Pacific: China, Japan, South Korea, India, ASEAN countries

Europe, Middle East & Africa (EMEA): Major European economies, GCC countries, and African nations

The report provides a region-wise breakdown of market share, consumption trends, and future prospects.

Detailed of Artificial Intelligence in Drug Discovery Market Segmentation -

The report offers great insights into important segments of the global Artificial Intelligence in Drug Discovery market while concentrating on their CAGR, market size, market share, and future growth potential. The global Artificial Intelligence in Drug Discovery market is mainly segmented according to type of product, application, and region. Each segment in these categories is extensively researched to become familiar with their growth prospects and key trends. Segmental analysis is highly important to identify key growth pockets of a global market. The report provides specific information on the market growth and demand of different products and applications to help players to focus on profitable areas of the global Artificial Intelligence in Drug Discovery market.

Segmentation By Type :-

Hardware
Software
Service

Segmentation By Application -

Early Drug Discovery
Preclinical Phase
Clinical Phase
Regulatory Approval

This segmentation helps identify high-growth opportunities and niche segments for investors and businesses.

Request for Pre-Order Enquiry On This Exclusive Report @ https://qyresearch.in/pre-order-inquiry/service-software-global-artificial-intelligence-in-drug-discovery-market-share-and-ranking-overall-sales-and-demand-forecast-2025-2031

Why This Report is a Must-Have -

ᗒ Historical Analysis (2020-2024) & Forecasts (2025-2031): Gain a clear understanding of market trends and future growth potential.

ᗒ Comprehensive Market Segmentation: Detailed breakdown by Type, Application, and Region to identify lucrative opportunities.

ᗒ Competitive Landscape: Insights into key players, their market share, and strategic developments like mergers, acquisitions, and expansion plans.

ᗒ Drivers & Restraints: Understand the factors shaping the market's growth and the challenges that could impact your strategy.

ᗒ Expert Opinions & Market Dynamics: Benefit from expert analysis to navigate market risks and capitalize on emerging trends.

Artificial Intelligence in Drug Discovery Market Report Objectives -

(1) Analyzing the size of the global Artificial Intelligence in Drug Discovery market on the basis of value and volume

(2) Accurately calculating the market shares, consumption, and other vital factors of different segments of the global Artificial Intelligence in Drug Discovery market

(3) Exploring key dynamics of the global Artificial Intelligence in Drug Discovery market

(4) Highlighting important trends of the global Artificial Intelligence in Drug Discovery market in terms of production, revenue, and sales

(5) Deeply profiling top players of the global Artificial Intelligence in Drug Discovery market and showing how they compete in the industry

(6) Studying manufacturing processes and costs, product pricing, and various trends related to them

(7) Showing the performance of different regions and countries in the global Artificial Intelligence in Drug Discovery market

(8) Forecasting the market size and share of all segments, regions, and the global market.

Important Questions Answered included in the Report:-

(A) What is the market size and growth rate of the global and regional market by various segments?

(B) What is the market size and growth rate of the market for selective Countries?

(C) Which region or sub-segment is expected to drive the market in the forecast period?

(D) What factors are estimated to drive and restrain the market growth?

(E) What are the key technology and market trends shaping the market?

(F) what are the key opportunity in the market?

(G) Who are the leading manufacturers operating in the global Artificial Intelligence in Drug Discovery market?

(H) Which key player accounted for the highest market share?

(I) What are the growth opportunities for the new entrants in the global Artificial Intelligence in Drug Discovery market?

Table of Contents - Major Key Points:

1 Market Overview
1.1 Artificial Intelligence in Drug Discovery Product Introduction
1.2 Global Artificial Intelligence in Drug Discovery Market Size Forecast (2020-2031)
1.3 Artificial Intelligence in Drug Discovery Market Trends & Drivers
1.3.1 Artificial Intelligence in Drug Discovery Industry Trends
1.3.2 Artificial Intelligence in Drug Discovery Market Drivers & Opportunity
1.3.3 Artificial Intelligence in Drug Discovery Market Challenges
1.3.4 Artificial Intelligence in Drug Discovery Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Artificial Intelligence in Drug Discovery Players Revenue Ranking (2024)
2.2 Global Artificial Intelligence in Drug Discovery Revenue by Company (2020-2025)
2.3 Key Companies Artificial Intelligence in Drug Discovery Manufacturing Base Distribution and Headquarters
2.4 Key Companies Artificial Intelligence in Drug Discovery Product Offered
2.5 Key Companies Time to Begin Mass Production of Artificial Intelligence in Drug Discovery
2.6 Artificial Intelligence in Drug Discovery Market Competitive Analysis
2.6.1 Artificial Intelligence in Drug Discovery Market Concentration Rate (2020-2025)
2.6.2 Global 5 and 10 Largest Companies by Artificial Intelligence in Drug Discovery Revenue in 2024
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Artificial Intelligence in Drug Discovery as of 2024)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Hardware
3.1.2 Software
3.1.3 Service
3.2 Global Artificial Intelligence in Drug Discovery Sales Value by Type
3.2.1 Global Artificial Intelligence in Drug Discovery Sales Value by Type (2020 VS 2024 VS 2031)
3.2.2 Global Artificial Intelligence in Drug Discovery Sales Value, by Type (2020-2031)
3.2.3 Global Artificial Intelligence in Drug Discovery Sales Value, by Type (%) (2020-2031)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Early Drug Discovery
4.1.2 Preclinical Phase
4.1.3 Clinical Phase
4.1.4 Regulatory Approval
4.2 Global Artificial Intelligence in Drug Discovery Sales Value by Application
4.2.1 Global Artificial Intelligence in Drug Discovery Sales Value by Application (2020 VS 2024 VS 2031)
4.2.2 Global Artificial Intelligence in Drug Discovery Sales Value, by Application (2020-2031)
4.2.3 Global Artificial Intelligence in Drug Discovery Sales Value, by Application (%) (2020-2031)
5 Segmentation by Region
5.1 Global Artificial Intelligence in Drug Discovery Sales Value by Region
5.1.1 Global Artificial Intelligence in Drug Discovery Sales Value by Region: 2020 VS 2024 VS 2031
5.1.2 Global Artificial Intelligence in Drug Discovery Sales Value by Region (2020-2025)
5.1.3 Global Artificial Intelligence in Drug Discovery Sales Value by Region (2026-2031)
5.1.4 Global Artificial Intelligence in Drug Discovery Sales Value by Region (%), (2020-2031)
5.2 North America
5.2.1 North America Artificial Intelligence in Drug Discovery Sales Value, 2020-2031
5.2.2 North America Artificial Intelligence in Drug Discovery Sales Value by Country (%), 2024 VS 2031
5.3 Europe
5.3.1 Europe Artificial Intelligence in Drug Discovery Sales Value, 2020-2031
5.3.2 Europe Artificial Intelligence in Drug Discovery Sales Value by Country (%), 2024 VS 2031
5.4 Asia Pacific
5.4.1 Asia Pacific Artificial Intelligence in Drug Discovery Sales Value, 2020-2031
5.4.2 Asia Pacific Artificial Intelligence in Drug Discovery Sales Value by Region (%), 2024 VS 2031
5.5 South America
5.5.1 South America Artificial Intelligence in Drug Discovery Sales Value, 2020-2031
5.5.2 South America Artificial Intelligence in Drug Discovery Sales Value by Country (%), 2024 VS 2031
5.6 Middle East & Africa
5.6.1 Middle East & Africa Artificial Intelligence in Drug Discovery Sales Value, 2020-2031
5.6.2 Middle East & Africa Artificial Intelligence in Drug Discovery Sales Value by Country (%), 2024 VS 2031
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Artificial Intelligence in Drug Discovery Sales Value Growth Trends, 2020 VS 2024 VS 2031
6.2 Key Countries/Regions Artificial Intelligence in Drug Discovery Sales Value, 2020-2031
6.3 United States
6.3.1 United States Artificial Intelligence in Drug Discovery Sales Value, 2020-2031
6.3.2 United States Artificial Intelligence in Drug Discovery Sales Value by Type (%), 2024 VS 2031
6.3.3 United States Artificial Intelligence in Drug Discovery Sales Value by Application, 2024 VS 2031
6.4 Europe
6.4.1 Europe Artificial Intelligence in Drug Discovery Sales Value, 2020-2031
6.4.2 Europe Artificial Intelligence in Drug Discovery Sales Value by Type (%), 2024 VS 2031
6.4.3 Europe Artificial Intelligence in Drug Discovery Sales Value by Application, 2024 VS 2031
6.5 China
6.5.1 China Artificial Intelligence in Drug Discovery Sales Value, 2020-2031
6.5.2 China Artificial Intelligence in Drug Discovery Sales Value by Type (%), 2024 VS 2031
6.5.3 China Artificial Intelligence in Drug Discovery Sales Value by Application, 2024 VS 2031
6.6 Japan
6.6.1 Japan Artificial Intelligence in Drug Discovery Sales Value, 2020-2031
6.6.2 Japan Artificial Intelligence in Drug Discovery Sales Value by Type (%), 2024 VS 2031
6.6.3 Japan Artificial Intelligence in Drug Discovery Sales Value by Application, 2024 VS 2031
6.7 South Korea
6.7.1 South Korea Artificial Intelligence in Drug Discovery Sales Value, 2020-2031
6.7.2 South Korea Artificial Intelligence in Drug Discovery Sales Value by Type (%), 2024 VS 2031
6.7.3 South Korea Artificial Intelligence in Drug Discovery Sales Value by Application, 2024 VS 2031
6.8 Southeast Asia
6.8.1 Southeast Asia Artificial Intelligence in Drug Discovery Sales Value, 2020-2031
6.8.2 Southeast Asia Artificial Intelligence in Drug Discovery Sales Value by Type (%), 2024 VS 2031
6.8.3 Southeast Asia Artificial Intelligence in Drug Discovery Sales Value by Application, 2024 VS 2031
6.9 India
6.9.1 India Artificial Intelligence in Drug Discovery Sales Value, 2020-2031
6.9.2 India Artificial Intelligence in Drug Discovery Sales Value by Type (%), 2024 VS 2031
6.9.3 India Artificial Intelligence in Drug Discovery Sales Value by Application, 2024 VS 2031
7 Company Profiles
7.1 IBM
7.1.1 IBM Profile
7.1.2 IBM Main Business
7.1.3 IBM Artificial Intelligence in Drug Discovery Products, Services and Solutions
7.1.4 IBM Artificial Intelligence in Drug Discovery Revenue (US$ Million) & (2020-2025)
7.1.5 IBM Recent Developments
7.2 Exscientia
7.2.1 Exscientia Profile
7.2.2 Exscientia Main Business
7.2.3 Exscientia Artificial Intelligence in Drug Discovery Products, Services and Solutions
7.2.4 Exscientia Artificial Intelligence in Drug Discovery Revenue (US$ Million) & (2020-2025)
7.2.5 Exscientia Recent Developments
7.3 Google(Alphabet)
7.3.1 Google(Alphabet) Profile
7.3.2 Google(Alphabet) Main Business
7.3.3 Google(Alphabet) Artificial Intelligence in Drug Discovery Products, Services and Solutions
7.3.4 Google(Alphabet) Artificial Intelligence in Drug Discovery Revenue (US$ Million) & (2020-2025)
7.3.5 Google(Alphabet) Recent Developments
7.4 Microsoft
7.4.1 Microsoft Profile
7.4.2 Microsoft Main Business
7.4.3 Microsoft Artificial Intelligence in Drug Discovery Products, Services and Solutions
7.4.4 Microsoft Artificial Intelligence in Drug Discovery Revenue (US$ Million) & (2020-2025)
7.4.5 Microsoft Recent Developments
7.5 Atomwise
7.5.1 Atomwise Profile
7.5.2 Atomwise Main Business
7.5.3 Atomwise Artificial Intelligence in Drug Discovery Products, Services and Solutions
7.5.4 Atomwise Artificial Intelligence in Drug Discovery Revenue (US$ Million) & (2020-2025)
7.5.5 Atomwise Recent Developments
7.6 Schrodinger
7.6.1 Schrodinger Profile
7.6.2 Schrodinger Main Business
7.6.3 Schrodinger Artificial Intelligence in Drug Discovery Products, Services and Solutions
7.6.4 Schrodinger Artificial Intelligence in Drug Discovery Revenue (US$ Million) & (2020-2025)
7.6.5 Schrodinger Recent Developments
7.7 Aitia
7.7.1 Aitia Profile
7.7.2 Aitia Main Business
7.7.3 Aitia Artificial Intelligence in Drug Discovery Products, Services and Solutions
7.7.4 Aitia Artificial Intelligence in Drug Discovery Revenue (US$ Million) & (2020-2025)
7.7.5 Aitia Recent Developments
7.8 Insilico Medicine
7.8.1 Insilico Medicine Profile
7.8.2 Insilico Medicine Main Business
7.8.3 Insilico Medicine Artificial Intelligence in Drug Discovery Products, Services and Solutions
7.8.4 Insilico Medicine Artificial Intelligence in Drug Discovery Revenue (US$ Million) & (2020-2025)
7.8.5 Insilico Medicine Recent Developments
7.9 NVIDIA
7.9.1 NVIDIA Profile
7.9.2 NVIDIA Main Business
7.9.3 NVIDIA Artificial Intelligence in Drug Discovery Products, Services and Solutions
7.9.4 NVIDIA Artificial Intelligence in Drug Discovery Revenue (US$ Million) & (2020-2025)
7.9.5 NVIDIA Recent Developments
7.10 XtalPi
7.10.1 XtalPi Profile
7.10.2 XtalPi Main Business
7.10.3 XtalPi Artificial Intelligence in Drug Discovery Products, Services and Solutions
7.10.4 XtalPi Artificial Intelligence in Drug Discovery Revenue (US$ Million) & (2020-2025)
7.10.5 XtalPi Recent Developments
7.11 BPGbio
7.11.1 BPGbio Profile
7.11.2 BPGbio Main Business
7.11.3 BPGbio Artificial Intelligence in Drug Discovery Products, Services and Solutions
7.11.4 BPGbio Artificial Intelligence in Drug Discovery Revenue (US$ Million) & (2020-2025)
7.11.5 BPGbio Recent Developments
7.12 Owkin
7.12.1 Owkin Profile
7.12.2 Owkin Main Business
7.12.3 Owkin Artificial Intelligence in Drug Discovery Products, Services and Solutions
7.12.4 Owkin Artificial Intelligence in Drug Discovery Revenue (US$ Million) & (2020-2025)
7.12.5 Owkin Recent Developments
7.13 CytoReason
7.13.1 CytoReason Profile
7.13.2 CytoReason Main Business
7.13.3 CytoReason Artificial Intelligence in Drug Discovery Products, Services and Solutions
7.13.4 CytoReason Artificial Intelligence in Drug Discovery Revenue (US$ Million) & (2020-2025)
7.13.5 CytoReason Recent Developments
7.14 Deep Genomics
7.14.1 Deep Genomics Profile
7.14.2 Deep Genomics Main Business
7.14.3 Deep Genomics Artificial Intelligence in Drug Discovery Products, Services and Solutions
7.14.4 Deep Genomics Artificial Intelligence in Drug Discovery Revenue (US$ Million) & (2020-2025)
7.14.5 Deep Genomics Recent Developments
7.15 Cloud Pharmaceuticals
7.15.1 Cloud Pharmaceuticals Profile
7.15.2 Cloud Pharmaceuticals Main Business
7.15.3 Cloud Pharmaceuticals Artificial Intelligence in Drug Discovery Products, Services and Solutions
7.15.4 Cloud Pharmaceuticals Artificial Intelligence in Drug Discovery Revenue (US$ Million) & (2020-2025)
7.15.5 Cloud Pharmaceuticals Recent Developments
7.16 BenevolentAI
7.16.1 BenevolentAI Profile
7.16.2 BenevolentAI Main Business
7.16.3 BenevolentAI Artificial Intelligence in Drug Discovery Products, Services and Solutions
7.16.4 BenevolentAI Artificial Intelligence in Drug Discovery Revenue (US$ Million) & (2020-2025)
7.16.5 BenevolentAI Recent Developments
7.17 Cyclica
7.17.1 Cyclica Profile
7.17.2 Cyclica Main Business
7.17.3 Cyclica Artificial Intelligence in Drug Discovery Products, Services and Solutions
7.17.4 Cyclica Artificial Intelligence in Drug Discovery Revenue (US$ Million) & (2020-2025)
7.17.5 Cyclica Recent Developments
7.18 Verge Genomics
7.18.1 Verge Genomics Profile
7.18.2 Verge Genomics Main Business
7.18.3 Verge Genomics Artificial Intelligence in Drug Discovery Products, Services and Solutions
7.18.4 Verge Genomics Artificial Intelligence in Drug Discovery Revenue (US$ Million) & (2020-2025)
7.18.5 Verge Genomics Recent Developments
7.19 Valo Health
7.19.1 Valo Health Profile
7.19.2 Valo Health Main Business
7.19.3 Valo Health Artificial Intelligence in Drug Discovery Products, Services and Solutions
7.19.4 Valo Health Artificial Intelligence in Drug Discovery Revenue (US$ Million) & (2020-2025)
7.19.5 Valo Health Recent Developments
7.20 Envisagenics
7.20.1 Envisagenics Profile
7.20.2 Envisagenics Main Business
7.20.3 Envisagenics Artificial Intelligence in Drug Discovery Products, Services and Solutions
7.20.4 Envisagenics Artificial Intelligence in Drug Discovery Revenue (US$ Million) & (2020-2025)
7.20.5 Envisagenics Recent Developments
7.21 Euretos
7.21.1 Euretos Profile
7.21.2 Euretos Main Business
7.21.3 Euretos Artificial Intelligence in Drug Discovery Products, Services and Solutions
7.21.4 Euretos Artificial Intelligence in Drug Discovery Revenue (US$ Million) & (2020-2025)
7.21.5 Euretos Recent Developments
7.22 BioAge Labs
7.22.1 BioAge Labs Profile
7.22.2 BioAge Labs Main Business
7.22.3 BioAge Labs Artificial Intelligence in Drug Discovery Products, Services and Solutions
7.22.4 BioAge Labs Artificial Intelligence in Drug Discovery Revenue (US$ Million) & (2020-2025)
7.22.5 BioAge Labs Recent Developments
7.23 Iktos
7.23.1 Iktos Profile
7.23.2 Iktos Main Business
7.23.3 Iktos Artificial Intelligence in Drug Discovery Products, Services and Solutions
7.23.4 Iktos Artificial Intelligence in Drug Discovery Revenue (US$ Million) & (2020-2025)
7.23.5 Iktos Recent Developments
7.24 BioSymetrics
7.24.1 BioSymetrics Profile
7.24.2 BioSymetrics Main Business
7.24.3 BioSymetrics Artificial Intelligence in Drug Discovery Products, Services and Solutions
7.24.4 BioSymetrics Artificial Intelligence in Drug Discovery Revenue (US$ Million) & (2020-2025)
7.24.5 BioSymetrics Recent Developments
7.25 Evaxion Biotech
7.25.1 Evaxion Biotech Profile
7.25.2 Evaxion Biotech Main Business
7.25.3 Evaxion Biotech Artificial Intelligence in Drug Discovery Products, Services and Solutions
7.25.4 Evaxion Biotech Artificial Intelligence in Drug Discovery Revenue (US$ Million) & (2020-2025)
7.25.5 Evaxion Biotech Recent Developments
7.26 Aria Pharmaceuticals, Inc
7.26.1 Aria Pharmaceuticals, Inc Profile
7.26.2 Aria Pharmaceuticals, Inc Main Business
7.26.3 Aria Pharmaceuticals, Inc Artificial Intelligence in Drug Discovery Products, Services and Solutions
7.26.4 Aria Pharmaceuticals, Inc Artificial Intelligence in Drug Discovery Revenue (US$ Million) & (2020-2025)
7.26.5 Aria Pharmaceuticals, Inc Recent Developments
8 Industry Chain Analysis
8.1 Artificial Intelligence in Drug Discovery Industrial Chain
8.2 Artificial Intelligence in Drug Discovery Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Artificial Intelligence in Drug Discovery Sales Model
8.5.2 Sales Channel
8.5.3 Artificial Intelligence in Drug Discovery Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer

About Us:

QYResearch established as a research firm in 2007 and have since grown into a trusted brand amongst many industries. Over the years, we have consistently worked toward delivering high-quality customized solutions for wide range of clients ranging from ICT to healthcare industries. With over 50,000 satisfied clients, spread over 80 countries, we have sincerely strived to deliver the best analytics through exhaustive research methodologies.

Contact Us:

Arshad Shaha | Marketing Executive

QY Research, INC.
315 Work Avenue, Raheja Woods,
Survey No. 222/1, Plot No. 25, 6th Floor,
Kayani Nagar, Yervada, Pune 411006, Maharashtra
Tel: +91-8669986909
Emails - arshad@qyrindia.com
Web - https://www.qyresearch.in

This release was published on openPR.